Moneycontrol
HomeNewsBusinessCompaniesL&T in talks with SBI, Telangana government to bail out cash-strapped Hyderabad metro rail project
Trending Topics

L&T in talks with SBI, Telangana government to bail out cash-strapped Hyderabad metro rail project

The Telangana government, however, has its own fiscal challenges due to the loss of tax revenue on account of Covid-19, a high debt burden and the recent floods that devastated capital city Hyderabad and its adjoining districts

October 29, 2020 / 12:25 IST
Story continues below Advertisement
Representative image

Larsen & Toubro (L&T), operator of the Hyderabad metro rail project, said it is in discussions with State Bank of India (SBI) and the Telangana government to make the project financially viable.

“There is huge finance involved; there are other aspects involved. We are in constant dialogue with the government of Telangana and (lead banker) SBI to see what is best from a financial point of view to refinance the project and make it viable,” said SN Subrahmanyan, CEO & MD of L&T, during the company’s post-earnings media call on Wednesday.

Story continues below Advertisement

Subrahmanyan said he was assured by Telangana Chief Minister K Chandrashekar Rao that the State would do what is required to get the metro rail project back on track.

“We are cautiously optimistic that better sense will prevail. This being a huge investment, the government also considers it as their project,” the L&T boss added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show